Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Otsuka Pharmaceutical Factory Inc patents

Recent patent applications related to Otsuka Pharmaceutical Factory Inc. Otsuka Pharmaceutical Factory Inc is listed as an Agent/Assignee. Note: Otsuka Pharmaceutical Factory Inc may have other listings under different names/spellings. We're not affiliated with Otsuka Pharmaceutical Factory Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "O" | Otsuka Pharmaceutical Factory Inc-related inventors

Method for producing port, and method for producing medical liquid bag

An object is to provide a method for producing a port that can shorten the time for production. Provided is a method for producing a port including: sealingly inserting a sealing plug, through which a hollow needle can be pierced, into a part to be sealed of a port body, wherein the port body includes: a part to be sealed that has a tubular shape with a first end and a second end opposite to the first end; a connection part that has a tubular shape, and is continuous with the first end of the part to be sealed; and the part to be fitted that is formed in any one of an inner peripheral surface of the part to be sealed, an outer peripheral surface of the part to be sealed, and the second end of the part to be sealed; fitting a fitting part of a pulling-out prevention member into the part to be fitted, wherein the pulling-out prevention member includes: a body part that has a first surface and a second surface opposite to the first surface, and the fitting part that is continuous with the body part; and laying the body part on the sealing plug.. ... Otsuka Pharmaceutical Factory Inc

Container for cell administration, storage or culturing

When mammal cells are administered by using a container whose surface in contact with the mammal cells is formed of a fluororesin material at least partially having a —cf3 terminal group or a container whose surface in contact with the mammal cells is formed of a fluororesin material having a total number of non-fluorinated group terminals and —cf2h group terminals in the fluororesin of 70 or less per 1×106 carbon atoms, or mammal cells are stored or cultured in such a container, the cell adhesion on the container inner surface and the cell survival rate reduction can effectively be suppressed. Therefore, by using these containers, a mammal cell-containing liquid having a high concentration and a high proportion of living cells can be administered, stored or prepared, which contributes to regenerative medicine using the mammal cell-containing liquid (suspension liquid).. ... Otsuka Pharmaceutical Factory Inc

Applicator for medical-use liquids

An applicator for medical-use liquids includes a handle having a hollow cylindrical member, a container incorporated in the cylindrical member, and a cleaving member of the container; and an applying section having an attachment plate of an application pad (integrally) fixed to a lower end of the cylindrical member to be an inclined cross section and the application pad fixed to the attachment plate. The attachment plate has a bank section formed thick at a peripheral edge, a base bottom section formed as a recess in a center, an inclined outflow hole opened inclinedly with respect to the base bottom section near the base bottom section center such that the solution flows out toward an attachment plate distal end direction, and a weir provided in an arcuate or crescent shape. ... Otsuka Pharmaceutical Factory Inc

Lid cover for medicine container

The present invention provides a lid cover (1) of a medicine container (2) for preventing a medicine, which is air-tightly stored in a medicine container (2) that has a lid portion (22) that can be pierced with a needle (33), from leaking to an outside space when the medicine is suctioned using a syringe (3) having the needle (33), the lid cover (1) including a peripheral wall portion (10) that can be mounted to the lid portion (22) so as to surround a piercing face of the lid portion (22) that is pierced with the needle (33) and a ceiling face portion (50) that is continuous with an upper portion of the peripheral wall portion (10), and can be pierced with the needle (33), wherein the peripheral wall portion (10) and the ceiling face portion (50) are made of an elastic material, and are configured to air-tightly store the piercing face such that the piercing face is not exposed to the outside space in a state where the peripheral wall portion (10) is mounted to the lid portion (22), while also forming a closed space between the piercing face and the ceiling face portion (50), and the ceiling face portion (50) has a central portion (51) that opposes the piercing face, and is pierced with the needle, and an outer periphery portion (52) that is formed in the periphery of the central portion (51), and is thinner than the central portion (51).. . ... Otsuka Pharmaceutical Factory Inc

Method for preparing pluripotent stem cells

An object of the present invention is to provide a method capable of inexpensively and conveniently preparing cells having pluripotency and a very low risk of tumorigenic transformation. The cells can be prepared by suspension-culturing mammalian mesenchymal stem cells such as human mesenchymal stem cells from bone marrow (hmsc-bm) and human adipose tissue-derived mesenchymal stem cells (hat-msc) (also referred to as “human adipose-derived stem cells [hadsc]”), 7 types of human adherent mature cells (human hepatocyte cells [hhep cells], human umbilical vein endothelial cells [huvec cells], human dermal lymphatic microvascular endothelial cells [hmvec cells], human epidermal keratinocyte cells [nhek cells], human bronchial epithelial cells [nhbe cells], human melanocyte cells [nhem cells], and human smooth muscle cells [uasmc cells]), and 3 types of human adherent precursor cells (human dermal fibroblast cells [nhdf cells], human skeletal muscle myoblast cells [hsmm cells], and human osteoblast cells [nhost cells]) to form cell masses (spheroids).. ... Otsuka Pharmaceutical Factory Inc

Infusion preparation

An object of the present invention is to provide an infusion preparation in which the maillard reaction between an amino acid and a reducing sugar does not occur during storage and the size of fat particles in the fat emulsion does not increase during storage, and in which various types of vitamins can be incorporated in a stable manner, in spite of the fact that it is a two-chamber infusion preparation. Furthermore, even if only one of the infusions (of the infusion preparation) is administered, the patient is unlikely to develop hyperkalemia, vascular pain, or phlebitis. ... Otsuka Pharmaceutical Factory Inc

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Otsuka Pharmaceutical Factory Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Otsuka Pharmaceutical Factory Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by